Qarzning balans qiymatiga nisbati: 10x (TXG)

10x Genomics, Inc. (TXG) kompaniyasining korporativ logotipi

Uskunalar savdosining pasayishi tufayli pul oqimi cheklanganiga qaramay, 10x Genomics, Inc. (TXG) patentlar va noelastik talab orqali o'zining tor doirali bozorida ustunlikka ega bo'lib, bu 0.11 ni tashkil etadi. GURU.Markets saytidagi ushbu narxlar grafigi ushbu DNK mahsulotlarini ishlab chiquvchining narxlar dinamikasini aks ettiradi. 10x Genomics, Inc. (TXG) dasturiy ta'minot va sarflanadigan materiallarning kombinatsiyasi mijozlarni o'zining texnologik standartiga qat'iy bog'lab qo'yadigan keng qamrovli ekotizimni yaratgan.

10x (TXG): Qarzning sof aktivlarga nisbati 04.07.2022dan 28.10.2026gacha

10x Genomics Inc (TXG) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi 10x Genomics, Inc.|TXG - Tahlilchilarning prognoz narxlari
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi 10x|TXG - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun buxgalteriya qiymati 10x Genomics|TXG - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati 10xgenomics.com|TXG - Kompaniyaning balans aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati 10x Genomics, Inc.|TXG - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati 10x Genomics Corp|TXG - Kompaniyaning jamlangan qarzi|Qarzning balans kapitallashuviga nisbati 10x
Kompaniyaning jamlanma tahliliyoti:10x Genomics, Inc. - TXG
10x Genomics Corp yetakchi tovari

10x Genomics, Inc. (TXG) kompaniyasida quvvatlardan barqaror foydalanish va robotlashtirilgan liniyalarni modernizatsiya qilish kengayish sur'atlarini saqlab qolish uchun moliyaviy tuzilma ustidan aniq nazoratni talab qiladi. Balansdagi moliyaviy leverajning dinamik tendentsiyasini tahlil qilish orqali investor qarzning kapitalga nisbati ko'rsatkichini baholaydi, bu esa bankrotlik xavflarini minimallashtirish va biznesni kengaytirish uchun leverajdan samarali foydalanish o'rtasidagi muvozanatni aniqlashga yordam beradi.

10x Genomics, Inc. kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar Tempus AI Inc (TEM)|QGEN - Qarzning balans kapitaliga nisbati|Ionis (IONS) - Qarzning balans qiymatiga nisbati|Repligen Corp (RGEN) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Avidity RNA|CRISPR (CRSP) - Qarzning sof aktivlarga nisbati|GeneDx Holdings Corp. - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati ultragenyx.com|Beam Therapeutics - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar SRPT (Sarepta Therapeutics)|TWST - Qarzning balans kapitallashuviga nisbati|Intellia Corp - Qarzning balans qiymatiga nisbati|STOK (Stoke Therapeutics) - Qarzning balans kapitallashuviga nisbati|BLFS: Balans qiymatiga qarzlar|WVE (Wave Life Sciences Ltd.) - Qarzning balans kapitallashuviga nisbati|Maze Therapeutics, Inc. (MAZE) - Qarzning balans qiymatiga nisbati|SION: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Prime Medicine Bio|Balans kapitallashuviga qarzlar TSHA (Taysha Gene Therapies)|Qarzning balans qiymatiga nisbati QURE (uniqure.com)|Qarzning balans kapitallashuviga nisbati MGTX|RGNX - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Solid Bio (SLDB)|OCGN - Qarzning sof aktivlarga nisbati|Pacific Biosciences - Balans kapitallashuviga qarzlar|BNTC (benitec.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Design Therapeutics, Inc. (DSGN)|Qarzning balans qiymatiga nisbati Rocket Pharma|Balans kapitallashuviga qarzlar FDMT (4D Molecular Therapeutics Inc)|Qarzning balans qiymatiga nisbati lexeotx.com LXEO|Qarzning balans qiymatiga nisbati KRRO|EDIT - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Silence Therapeutics plc SLN|ProQR Therapeutics N.V. (PRQR) - Qarzning balans kapitaliga nisbati|Qarzning balans qiymatiga nisbati codexis.com|Sangamo BioSciences (SGMO) - Qarzning balans qiymatiga nisbati|Nautilus Biotechnology, Inc. - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati metagenomi.co|Balans kapitallashuviga qarzlar Precision BioSciences, Inc. DTIL|Qarzning balans qiymatiga nisbati GBIO (generationbio.com)|BOLD - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Exicure Inc. XCUR|Celsion Corporation - Balans kapitallashuviga qarzlar|PHIO - Balans kapitallashuviga qarzlar|MBIO - Balans kapitallashuviga qarzlar|Qarzning balans kapitaliga nisbati TransCode Therapeutics, Inc.|Qarzning balans qiymatiga nisbati Bionano Genomics Inc. (BNGO)|Qarzning balans qiymatiga nisbati Applied DNA Corp (APDN)|bluebird bio, Inc. (BLUE) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati immunoprecise.com (IPA)|OMGA (Omega Therapeutics, Inc.) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Singular Genomics Systems, Inc. OMIC|RGLS (Regulus Therapeutics Inc) - Balans kapitallashuviga qarzlar|SYRS: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Telesis Bio, Inc.|TCON (traconpharma.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati UBX (Unity Biotechnology, Inc.)